These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33618193)

  • 1. Within-treatment clinical markers of dropout risk in integrated treatments for comorbid PTSD and alcohol use disorder.
    Kline AC; Panza KE; Harlé KM; Angkaw AC; Trim RS; Back SE; Norman SB
    Drug Alcohol Depend; 2021 Apr; 221():108592. PubMed ID: 33618193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Integrated Exposure Therapy vs Integrated Coping Skills Therapy for Comorbid Posttraumatic Stress Disorder and Alcohol Use Disorder: A Randomized Clinical Trial.
    Norman SB; Trim R; Haller M; Davis BC; Myers US; Colvonen PJ; Blanes E; Lyons R; Siegel EY; Angkaw AC; Norman GJ; Mayes T
    JAMA Psychiatry; 2019 Aug; 76(8):791-799. PubMed ID: 31017639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance use predictors of attendance among veterans in integrated PTSD and alcohol use disorder treatment.
    Kline AC; Straus E; Lyons RC; Angkaw AC; Davis BC; Haller M; Hien D; Norman SB
    J Subst Abuse Treat; 2021 May; 124():108278. PubMed ID: 33771279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of treatment dropout: PTSD, depression, and alcohol use disorder reductions in PTSD and AUD/SUD treatment noncompleters.
    Szafranski DD; Gros DF; Acierno R; Brady KT; Killeen TK; Back SE
    Clin Psychol Psychother; 2019 Mar; 26(2):218-226. PubMed ID: 30419153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance use disorders and PTSD: Examining substance use, PTSD symptoms, and dropout following imaginal exposure.
    Jarnecke AM; Allan NP; Badour CL; Flanagan JC; Killeen TK; Back SE
    Addict Behav; 2019 Mar; 90():35-39. PubMed ID: 30355535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated, exposure-based treatment for PTSD and comorbid substance use disorders: Predictors of treatment dropout.
    Szafranski DD; Snead A; Allan NP; Gros DF; Killeen T; Flanagan J; Pericot-Valverde I; Back SE
    Addict Behav; 2017 Oct; 73():30-35. PubMed ID: 28460246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual Symptoms of Posttraumatic Stress Disorder and Alcohol Use Disorder Following Integrated Exposure Treatment Versus Coping Skills Treatment.
    Tripp JC; Angkaw A; Schnurr PP; Trim RS; Haller M; Davis BC; Norman SB
    J Trauma Stress; 2020 Aug; 33(4):477-487. PubMed ID: 32557843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of dropout in concurrent treatment of posttraumatic stress disorder and alcohol dependence: Rate of improvement matters.
    Zandberg LJ; Rosenfield D; Alpert E; McLean CP; Foa EB
    Behav Res Ther; 2016 May; 80():1-9. PubMed ID: 26972745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resting-state connectivity subtype of comorbid PTSD and alcohol use disorder moderates improvement from integrated prolonged exposure therapy in Veterans.
    Stout DM; Harlé KM; Norman SB; Simmons AN; Spadoni AD
    Psychol Med; 2023 Jan; 53(2):332-341. PubMed ID: 33926595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-treatment predictors of dropout from prolonged exposure therapy in patients with chronic posttraumatic stress disorder and comorbid substance use disorders.
    Belleau EL; Chin EG; Wanklyn SG; Zambrano-Vazquez L; Schumacher JA; Coffey SF
    Behav Res Ther; 2017 Apr; 91():43-50. PubMed ID: 28147254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining sleep over time in a randomized control trial comparing two integrated PTSD and alcohol use disorder treatments.
    Colvonen PJ; Straus LD; Drummond SPA; Angkaw AC; Norman SB
    Drug Alcohol Depend; 2020 Apr; 209():107905. PubMed ID: 32065939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing Exposure- and Coping Skills-Based Treatments on Trauma-Related Guilt in Veterans With Co-Occurring Alcohol Use and Posttraumatic Stress Disorders.
    Capone C; Tripp JC; Trim RS; Davis BC; Haller M; Norman SB
    J Trauma Stress; 2020 Aug; 33(4):603-609. PubMed ID: 32521096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subgroups of comorbid PTSD and AUD in U.S. military veterans predict differential responsiveness to two integrated treatments: A latent class analysis.
    Panza KE; Kline AC; Norman GJ; Pitts M; Norman SB
    J Psychiatr Res; 2021 May; 137():342-350. PubMed ID: 33756376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectional relationship of posttraumatic stress disorder (PTSD) symptom severity and alcohol use over the course of integrated treatment.
    Tripp JC; Worley MJ; Straus E; Angkaw AC; Trim RS; Norman SB
    Psychol Addict Behav; 2020 Jun; 34(4):506-511. PubMed ID: 32105112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining attendance patterns across integrated therapies for posttraumatic stress disorder and alcohol use disorder.
    Straus E; Worley MJ; Lyons R; Kline AC; Tripp JC; Davis BC; Haller M; Angkaw AC; Trim RS; Norman SB
    J Anxiety Disord; 2022 Jan; 85():102498. PubMed ID: 34823044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Randomized Controlled Pilot Trial of Primary Care Treatment Integrating Motivation and Exposure Treatment (PC-TIME) in Veterans With PTSD and Harmful Alcohol Use.
    Possemato K; Mastroleo NR; Balderrama-Durbin C; King P; Davis A; Borsari B; Rauch SAM
    Behav Ther; 2024 May; 55(3):570-584. PubMed ID: 38670669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No Wrong Doors: Findings from a Critical Review of Behavioral Randomized Clinical Trials for Individuals with Co-Occurring Alcohol/Drug Problems and Posttraumatic Stress Disorder.
    Simpson TL; Lehavot K; Petrakis IL
    Alcohol Clin Exp Res; 2017 Apr; 41(4):681-702. PubMed ID: 28055143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentations, social functioning, and treatment receipt among individuals with comorbid life-time PTSD and alcohol use disorders versus drug use disorders: findings from NESARC-III.
    Simpson TL; Rise P; Browne KC; Lehavot K; Kaysen D
    Addiction; 2019 Jun; 114(6):983-993. PubMed ID: 30694592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating "types" of treatment dropout: Nonstarters in an RCT of prolonged exposure versus sertraline.
    Kline AC; Baier AL; Klein AB; Feeny NC; Zoellner LA
    Behav Res Ther; 2020 Dec; 135():103750. PubMed ID: 33035741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans.
    Back SE; Killeen T; Badour CL; Flanagan JC; Allan NP; Ana ES; Lozano B; Korte KJ; Foa EB; Brady KT
    Addict Behav; 2019 Mar; 90():369-377. PubMed ID: 30529244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.